PTC THERAPEUTICS INC (PTCT)

US69366J2006 - Common Stock

45.84  +0.49 (+1.08%)

After market: 45.84 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
538.6M
41.44%
698.8M
29.74%
937.822M
34.20%
810.14M
-13.61%
923.16M
13.95%
907.8M
-1.66%
1.028B
13.24%
1.215B
18.19%
1.445B
18.93%
1.597B
10.52%
1.529B
-4.26%
EBITDA
YoY % growth
-310.27M
17.85%
-285.16M
8.09%
14.888M
105.22%
-77.252M
-618.89%
-32.311M
58.17%
84.872M
362.67%
N/AN/AN/AN/AN/A
EBIT
YoY % growth
-374.4M
11.11%
-414M
-10.58%
-221.702M
46.45%
-186.942M
15.68%
-180.607M
3.39%
-15.043M
91.67%
166.44M
1,206.42%
344.73M
107.12%
514.27M
49.18%
638.53M
24.16%
612.35M
-4.10%
Operating Margin
-69.51%-59.24%-23.64%-23.08%-19.56%-1.66%16.19%28.37%35.59%39.98%40.05%
EPS
YoY % growth
-7.43
-13.61%
-7.33
1.35%
-6.54
10.78%
-4.84
25.92%
-0.70
85.65%
-1.71
-146.40%
1.95
213.71%
3.77
93.46%
4.40
16.64%
5.21
18.56%
5.80
11.25%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27
EPS
Q2Q % growth
-1.05
-339.29%
-1.11
7.77%
-0.98
22.51%
-0.84
39.89%
-0.56
46.89%
-0.35
68.66%
-0.12
87.56%
0.07
108.55%
0.17
130.97%
0.61
276.47%
0.69
666.67%
0.67
842.86%
Revenue
Q2Q % growth
195.72M
-36.26%
170.47M
-18.87%
174.27M
-6.66%
195M
-0.91%
222.49M
13.68%
261.09M
53.16%
297.08M
70.47%
331.59M
70.05%
345.55M
55.31%
392.54M
50.35%
423.51M
42.56%
441.32M
33.09%
EBITDA
Q2Q % growth
-55.483M
-122.89%
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-45.516M
-882.07%
-59.194M
-30.23%
-46.376M
-20.59%
-33.524M
36.35%
-6.392M
85.96%
N/AN/AN/AN/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-1.39
21.02%
-1.470.085.49%
Q2 2024
Q2Q % growth
-1.27
52.26%
-1.07-0.20-18.68%
Q1 2024
Q2Q % growth
-1.20
36.17%
-1.270.075.18%
Q4 2023
Q2Q % growth
-0.24
87.30%
0.51-0.75-147.48%
Q3 2023
Q2Q % growth
-1.76
-15.03%
-1.19-0.57-47.41%
Q2 2023
Q2Q % growth
-2.66
-24.88%
-1.27-1.39-109.52%
Q1 2023
Q2Q % growth
-1.88
-5.62%
-1.32-0.56-41.94%
Q4 2022
Q2Q % growth
-1.89
6.90%
-1.62-0.27-16.38%
Q3 2022
Q2Q % growth
-1.53
19.05%
-1.27-0.26-20.74%
Q2 2022
Q2Q % growth
-2.13
-26.79%
-1.36-0.77-56.73%
Q1 2022
Q2Q % growth
-1.78
2.73%
-1.54-0.24-15.81%
Q4 2021
Q2Q % growth
-2.03
-87.96%
-1.68-0.35-20.96%
Q3 2021
Q2Q % growth
-1.89
-83.50%
-1.52-0.37-24.74%
Q2 2021
Q2Q % growth
-1.68
35.88%
-1.850.179.39%
Q1 2021
Q2Q % growth
-1.83
-1.10%
-1.54-0.29-18.59%
Q4 2020
Q2Q % growth
-1.08
21.17%
-0.95-0.13-13.15%
Q3 2020
Q2Q % growth
-1.03
2.83%
-0.06-0.97-1,674.08%
Q2 2020
Q2Q % growth
-2.62
-249.33%
-1.33-1.29-97.71%
Q1 2020
Q2Q % growth
-1.81
-40.31%
-1.35-0.46-33.60%
Q4 2019
Q2Q % growth
-1.37
-136.21%
-0.52-0.85-165.09%
Q3 2019
Q2Q % growth
-1.06 -0.77-0.29-37.42%
Q2 2019
Q2Q % growth
-0.75
-257.14%
-0.60-0.15-25.71%
Q1 2019
Q2Q % growth
-1.29
-180.43%
-0.78-0.51-66.22%
Q4 2018
Q2Q % growth
-0.58 -0.32-0.26-79.30%
Q3 2018
Q2Q % growth
-1.06 -0.41-0.65-158.83%
Q2 2018
Q2Q % growth
-0.21 -0.290.0828.06%
Q1 2018
Q2Q % growth
-0.46 -0.44-0.02-5.00%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
196.786M
0.11%
176.11M20.676M11.74%
Q2 2024
Q2Q % growth
186.704M
-12.68%
189.03M-2.326M-1.23%
Q1 2024
Q2Q % growth
210.118M
-4.66%
173.1M37.018M21.39%
Q4 2023
Q2Q % growth
307.056M
83.43%
327.72M-20.664M-6.31%
Q3 2023
Q2Q % growth
196.576M
-9.45%
214.4M-17.824M-8.31%
Q2 2023
Q2Q % growth
213.808M
29.19%
211.13M2.678M1.27%
Q1 2023
Q2Q % growth
220.382M
48.21%
204.49M15.892M7.77%
Q4 2022
Q2Q % growth
167.4M
1.33%
192.92M-25.52M-13.23%
Q3 2022
Q2Q % growth
217.1M
56.52%
190.64M26.46M13.88%
Q2 2022
Q2Q % growth
165.5M
41.82%
165.33M170K0.10%
Q1 2022
Q2Q % growth
148.7M
26.12%
150M-1.3M-0.87%
Q4 2021
Q2Q % growth
165.2M
38.94%
153.85M11.35M7.38%
Q3 2021
Q2Q % growth
138.7M
17.15%
122.85M15.85M12.90%
Q2 2021
Q2Q % growth
116.7M
55.19%
112.71M3.99M3.54%
Q1 2021
Q2Q % growth
117.9M
72.62%
100.78M17.12M16.99%
Q4 2020
Q2Q % growth
118.9M
23.21%
113.58M5.32M4.68%
Q3 2020
Q2Q % growth
118.4M
65.83%
114.45M3.95M3.45%
Q2 2020
Q2Q % growth
75.2M
-12.05%
84.434M-9.234M-10.94%
Q1 2020
Q2Q % growth
68.3M
27.43%
81.664M-13.364M-16.36%
Q4 2019
Q2Q % growth
96.5M
11.82%
97.15M-650K-0.67%
Q3 2019
Q2Q % growth
71.4M
33.21%
74.482M-3.082M-4.14%
Q2 2019
Q2Q % growth
85.5M
24.45%
80.211M5.289M6.59%
Q1 2019
Q2Q % growth
53.6M
-4.46%
71.407M-17.807M-24.94%
Q4 2018
Q2Q % growth
86.3M 87.177M-877K-1.01%
Q3 2018
Q2Q % growth
53.6M 72.322M-18.722M-25.89%
Q2 2018
Q2Q % growth
68.7M 67.014M1.686M2.52%
Q1 2018
Q2Q % growth
56.1M 57.849M-1.749M-3.02%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 41.53% 5.9% 6.29%
Revenue0% 34.76% 6.3% 7.77%